通过专为投资者打造的一站式数据看板，全面查看 Amylyx Pharmaceuticals Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图，助您更轻松地进行财务分析。您可以查看最新年度财务报告，也可以通过利润表、资产负债表和现金流量表，按季度分析公司表现。借助实时财务指标，持续追踪公司的经营状况和市场表现更加便捷。

关键财务比率

总市值

3.61B

股息TTM

0.00

市盈率 TTM

-21.83

每股收益TTM

-1.48

营业收入

0.00

净利润

-301.74M

净资产收益率

-63.26%

总资产收益率

-58.49%

Amylyx Pharmaceuticals Inc 财报日历

财务报表摘要

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

财务指标

每股收益

16.01%-0.39

10.88%-0.37

45.20%-0.30

65.50%-0.37

56.50%-0.46

76.07%-0.42

-881.69%-0.55

-444.52%-1.07

-425.51%-1.07

-7524.55%-1.75

110.74%0.07

--0.31

--0.33

--0.02

---0.65

---2.77

----

营业收入

--0.00

100.00%0.00

-100.00%0.00

100.00%0.00

-100.00%0.00

-100.61%-665.00K

-99.59%416.00K

-101.04%-1.02M

24.10%88.64M

395.54%108.45M

29666.09%102.69M

--98.22M

--71.43M

--21.89M

--345.00K

----

-100.00%0.00

----

净利润

-4.78%-43.42M

-14.97%-41.28M

12.11%-33.00M

52.70%-34.39M

42.99%-41.44M

69.77%-35.91M

-893.62%-37.55M

-447.98%-72.70M

-429.35%-72.70M

-7652.00%-118.79M

111.08%4.73M

138.87%20.89M

140.83%22.07M

103.29%1.57M

-50.66%-42.70M

---53.76M

-146.63%-54.07M

-229.46%-47.85M

-229.89%-28.34M

----

---21.92M

利润率

----

-86002.33%-17476.92%

----

-6185.35%-134.01%

102.24%4.36%

--20.35%

--22.47%

--2.20%

---195.13%

---45122.03%

----

毛利率

----

-199.53%-94.47%

----

-21.14%73.03%

4.89%91.37%

--94.92%

--94.32%

--92.60%

--87.11%

--50.14%

----

资产负债率

----

--0.00%

----

利润表

营业收入

--0.00

100.00%0.00

-100.00%0.00

100.00%0.00

-100.00%0.00

-100.61%-665.00K

-99.59%416.00K

-101.04%-1.02M

24.10%88.64M

395.54%108.45M

29666.09%102.69M

--98.22M

--71.43M

--21.89M

--345.00K

----

-100.00%0.00

----

营业利润

-6.62%-45.69M

-15.81%-43.78M

9.96%-36.60M

8.70%-36.03M

19.80%-42.86M

-27.58%-37.80M

-2202.07%-40.65M

-310.78%-39.46M

-364.52%-53.44M

-1343.25%-29.63M

104.34%1.93M

134.23%18.72M

137.23%20.20M

95.71%-2.05M

-57.49%-44.59M

---54.68M

-191.89%-54.25M

-271.57%-47.81M

-229.55%-28.32M

----

---18.59M

净利润

-4.78%-43.42M

-14.97%-41.28M

12.11%-33.00M

52.70%-34.39M

42.99%-41.44M

69.77%-35.91M

-893.62%-37.55M

-447.98%-72.70M

-429.35%-72.70M

-7652.00%-118.79M

111.08%4.73M

138.87%20.89M

140.83%22.07M

103.29%1.57M

-50.66%-42.70M

---53.76M

-146.63%-54.07M

-229.46%-47.85M

-229.89%-28.34M

----

---21.92M

资产负债表

流动资产

37.16%256.34M

31.87%285.02M

70.86%323.67M

44.08%353.38M

-42.80%186.89M

-47.35%216.14M

-59.23%189.43M

-43.50%245.26M

-23.55%326.72M

5.52%410.53M

21.60%464.67M

152.10%434.11M

97.74%427.39M

46.54%389.05M

264.11%382.13M

32.52%172.20M

--216.14M

--265.49M

--104.95M

--129.94M

----

流动负债总额

-1.28%21.15M

-10.96%15.97M

-20.13%22.69M

-52.16%25.79M

-69.43%21.42M

-80.43%17.93M

-65.38%28.41M

18.19%53.91M

9.36%70.08M

77.54%91.64M

76.02%82.04M

39.73%45.62M

135.91%64.08M

86.30%51.62M

167.93%46.61M

115.55%32.65M

--27.16M

--27.71M

--17.40M

--15.15M

----

总资产

35.95%264.56M

33.65%293.60M

71.79%332.64M

44.68%362.74M

-41.41%194.60M

-47.38%219.68M

-62.58%193.63M

-46.27%250.71M

-26.77%332.16M

2.33%417.46M

32.19%517.45M

157.15%466.58M

101.38%453.59M

48.65%407.96M

270.64%391.45M

39.08%181.44M

--225.24M

--274.44M

--105.61M

--130.46M

----

总负债

-4.95%25.40M

11.96%20.44M

-5.14%27.39M

-43.60%30.75M

-62.29%26.72M

-80.37%18.26M

-65.64%28.87M

13.13%54.51M

5.40%70.85M

68.18%93.02M

65.25%84.02M

28.78%48.18M

107.15%67.22M

65.14%55.31M

191.70%50.85M

146.49%37.41M

--32.45M

--33.49M

--17.43M

--15.18M

----

总权益

42.47%239.17M

35.62%273.16M

85.27%305.26M

69.21%332.00M

-35.76%167.88M

-37.92%201.42M

-61.99%164.76M

-53.11%196.20M

-32.37%261.31M

-8.00%324.44M

27.25%433.43M

190.50%418.40M

100.41%386.37M

46.36%352.65M

286.25%340.61M

24.94%144.03M

--192.79M

--240.95M

--88.18M

--115.28M

----

现金流量表

经营净额

-24.46%-31.42M

7.39%-36.88M

52.71%-27.90M

26.95%-30.37M

62.08%-25.25M

-8043.97%-39.82M

-535.45%-59.01M

-704.22%-41.57M

-873.38%-66.58M

90.36%-489.00K

127.27%13.55M

88.00%-5.17M

118.53%8.61M

87.52%-5.07M

-75.96%-49.70M

---43.08M

-256.11%-46.46M

-221.40%-40.63M

-217.78%-28.24M

----

---13.05M

投资净额

-751.46%-149.80M

183.06%36.26M

-54.65%29.47M

-86.51%5.24M

179.40%22.99M

-5430.77%-43.66M

210.54%64.98M

135.91%38.82M

-123.50%-28.96M

-98.54%819.00K

109.17%20.93M

-228.61%-108.09M

2661.59%123.22M

156.38%55.99M

-8208.74%-228.18M

--84.04M

--4.46M

-709264.29%-99.31M

1963.58%2.81M

----

--0.00

融资净额

4870.97%1.48M

-95.10%3.22M

-289.09%-208.00K

239407.50%191.61M

-214.81%-31.00K

50023.66%65.66M

-52.17%110.00K

-91.00%80.00K

-98.05%27.00K

-87.40%131.00K

-99.90%230.00K

--889.00K

267.15%1.38M

-99.48%1.04M

21899.25%232.16M

--0.00

-141.55%-828.00K

673.15%200.46M

-190.41%-1.06M

----

--1.99M

营业收入

业务

报告期:

暂无数据

地区

报告期:

暂无数据

常见问题

Amylyx Pharmaceuticals Inc的流动资产是多少？



根据Amylyx Pharmaceuticals Inc的FY2025财报，流动资产为323.67M（同比变化70.86）。

Amylyx Pharmaceuticals Inc的总资产是多少？



根据Amylyx Pharmaceuticals Inc的FY2025财报，Amylyx Pharmaceuticals Inc的总资产为332.64M（同比变化71.79）。

Amylyx Pharmaceuticals Inc的总负债是多少？



根据Amylyx Pharmaceuticals Inc的FY2025财报，Amylyx Pharmaceuticals Inc的总负债为27.39M（同比变化-5.14）。

Amylyx Pharmaceuticals Inc的总权益是多少？



根据Amylyx Pharmaceuticals Inc的FY2025财报，Amylyx Pharmaceuticals Inc的总权益为305.26M（同比变化85.27）。

Amylyx Pharmaceuticals Inc的净营业收入是多少？



根据Amylyx Pharmaceuticals Inc的FY2025财报，Amylyx Pharmaceuticals Inc的净营业收入为-153.29M（同比变化6.06）。

Amylyx Pharmaceuticals Inc的净投资是多少？



根据Amylyx Pharmaceuticals Inc的FY2025财报，Amylyx Pharmaceuticals Inc的净投资为14.04M（同比变化-81.44）。

Amylyx Pharmaceuticals Inc的净融资是多少？



根据Amylyx Pharmaceuticals Inc的FY2025财报，Amylyx Pharmaceuticals Inc的净融资为257.03M（同比变化73758.91）。

Amylyx Pharmaceuticals Inc的每股收益（EPS）是多少？



根据Amylyx Pharmaceuticals Inc的FY2025财报，每股收益（EPS）为-1.53（同比变化65.44）。

Amylyx Pharmaceuticals Inc的净利润是多少？



根据Amylyx Pharmaceuticals Inc的FY2025财报，净利润为-144.74M（同比变化52.03）。

Amylyx Pharmaceuticals Inc的股东权益回报率（ROE）是多少？



根据Amylyx Pharmaceuticals Inc的FY2025财报，股东权益回报率（ROE）为-61.59（同比变化38.95）。

Amylyx Pharmaceuticals Inc的资产回报率（ROA）是多少？



根据Amylyx Pharmaceuticals Inc的FY2025财报，资产回报率（ROA）为-55.00（同比变化35.19）。

Amylyx Pharmaceuticals Inc的营业利润是多少？



根据Amylyx Pharmaceuticals Inc的FY2025财报，营业利润为-153.29M（同比变化6.06）。